Results 351 to 360 of about 11,998,196 (407)
A Systematic Bibliometric Analysis of Cardiovascular Disease Risk in Obesity (2014-2024). [PDF]
J Multidiscip HealthcYang H +7 more
europepmc +1 more source
Glatiramer Acetate Reduces Risk of Cardiovascular Disease and Myocardial Infarction. [PDF]
In VivoLehrer S, Rheinstein PH.
europepmc +1 more source
Cardiovascular disease and radiopharmaceutical therapies- an underestimated risk? [PDF]
Eur J Nucl Med Mol ImagingLassmann M, Eberlein U, Verburg FA.
europepmc +1 more source
Dichotomous roles of IL-36 and IL-38 in cardiovascular disease. [PDF]
Front ImmunolZhang H, Huang W, Bao S.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
JAMA, 1989
The Thrombolysis in Myocardial Ischemia trial randomized patients with unstable angina or non-Q-wave myocardial infarction and found that thrombolytic therapy was not beneficial and may be harmful. Drug treatment of hypercholesterolemia improves survival in patients with established coronary artery disease.
J M, Gore, J E, Dalen
openaire +11 more sources
The Thrombolysis in Myocardial Ischemia trial randomized patients with unstable angina or non-Q-wave myocardial infarction and found that thrombolytic therapy was not beneficial and may be harmful. Drug treatment of hypercholesterolemia improves survival in patients with established coronary artery disease.
J M, Gore, J E, Dalen
openaire +11 more sources
COVID-19 and Cardiovascular Disease
Circulation, 2020Coronavirus disease 2019 (COVID-19) is a global pandemic affecting 185 countries and >3 000 000 patients worldwide as of April 28, 2020. COVID-19 is caused by severe acute respiratory syndrome coronavirus 2, which invades cells through the angiotensin ...
K. Clerkin +11 more
semanticscholar +1 more source